Britain's biotechnology industry is retaining its lead in Europe in terms of revenue and research and development expenditure.
But a report from the UK Office of Health Economics and the German Wissenschaftzentrum Berlin fur Sozialforschung expresses concern that the country is failing to maintain momentum and promote technology transfer.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.